Report of a case of anaplastic large cell lymphoma associated with a breast implant
            in a Brazilian patient

Batista, Bernardo Nogueira; Garicochea, Bernardo; Aguilar, V; Carvalho, Filomena Marino; Millan, Lincoln Saito; Fraga, Murillo Francisco Pires; Sampaio, Marcelo M. C.; Barros, Alfredo Carlos Simões Dornellas de

doi:10.5935/2177-1235.2017rbcp0073

Cited by 6 publications

(6 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…A literature review found five previous publications that included the diagnosis of BIA-ALCL in a Brazilian national. 7,[9][10][11]13 These publications included a total of 15 patients with BIA-ALCL and are summarized in Table 1. Although no clinical results are reported in 10 of these cases, 7 this brought the total number of published BIA-ALCL cases in Brazil to 29.…”

Section: Resultsmentioning

confidence: 99%

“…Few cases of BIA-ALCL in the Brazilian population have been reported in the medical literature. [7][8][9][10][11] The purpose of this article is to present the first prospective registry of BIA-ALCL in the Brazilian population using a process developed by a local task force to increase awareness, diagnosis, and registration, and analyze outcomes of published national cases.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Breast Implant–Associated Anaplastic Large-Cell Lymphoma in Brazil: What Are We Missing?

Groth

Clemens

Graf

et al. 2022

Plastic &Amp; Reconstructive Surgery

View full text Add to dashboard Cite

Background: Breast implant–associated anaplastic large-cell lymphoma (BIA-ALCL) has been diagnosed in more than 1000 patients in more than 30 countries, although only a few cases have been reported in Latin America and the Caribbean to date. As the second-largest global market for breast implants with a predominance of textured-surface implants, Brazil is a major global market for cosmetic augmentations, making it unlikely that cases of BIA-ALCL are actually scarce. Methods: A local and voluntary registry of patients with BIA-ALCL was initiated in 2018. All patients diagnosed with BIA-ALCL were confirmed by the World Health Organization criteria. Implant characteristics, disease symptoms, treatment, and oncologic outcomes were assessed. Results: Fourteen cases of BIA-ALCL in a Brazilian population were identified in the Paraná state. Disease-specific diagnostic tests were omitted before surgical intervention in 50 percent of patients. With additional cases from a literature review, the treatment and outcomes of 29 cases of BIA-ALCL in Brazil were assessed. Conclusions: Compared with other populations, these initial observations suggest that awareness of the disease by the local breast surgery community remains low and that a number of cases may remain undiagnosed. Lack of preoperative diagnostic testing compromises disease treatment, oncologic outcomes, and both short- and long-term surveillance.

show abstract

Section: Resultsmentioning

confidence: 99%

mentioning

confidence: 99%

Breast Implant–Associated Anaplastic Large-Cell Lymphoma in Brazil: What Are We Missing?

Groth

Clemens

Graf

et al. 2022

Plastic &Amp; Reconstructive Surgery

View full text Add to dashboard Cite

show abstract

“…The first association between ALCL and breast implants was established in 1997 by Keech et al 5 in a series of 46 cases diagnosed in Australia and New Zealand. Since then, different cases and case series have been described in the literature, with the largest series including no more than 200 cases [6][7][8][9][10][11][12] .…”

Section: Historical Backgroundmentioning

confidence: 99%

Anaplastic large cell lymphoma associated with breast implants. Importance for the surgeon

Martínez-Ramos¹,

Simón-Monterde²,

Suelves-Piqueres³

et al. 2019

CIRUE

View full text Add to dashboard Cite

Breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL) is an infrequent disease, although the number of cases has increased in the recent years. BIA-ALCL is revealed during medical screening as an increase in the mammary volume due to periprosthetic effusion or as a capsular mass. Preferred treatment for BIA-ALCL is surgery, with explantation of the prostheses and exeresis of the periprosthetic capsule. Prognosis, after early diagnosis and adequate treatment, is good. The objective of the present work was to review the existing scientific literature on BIA-ALCL and to show the importance of this type of neoplasia for a successful treatment.

show abstract

“…La primera asociación entre el ALCL y los implantes mamarios la establecieron en 1997 Keech, et al 5 en una serie de 46 casos diagnosticados en Australia y Nueva Zelanda. Desde entonces se han descrito diferentes casos y series de casos en la literatura, la mayor de ellas con menos de 200 casos incluidos [6][7][8][9][10][11][12] .…”

Section: Antecedentes Históricosunclassified

Linfoma anaplásico de células grandes asociado a implantes mamarios. Importancia para el cirujano

Martínez-Ramos¹,

Simón-Monterde²,

Suelves-Piqueres³

et al. 2018

CIRU

View full text Add to dashboard Cite

show abstract

Report of a case of anaplastic large cell lymphoma associated with a breast implant in a Brazilian patient

Cited by 6 publications

References 0 publications

Breast Implant–Associated Anaplastic Large-Cell Lymphoma in Brazil: What Are We Missing?

Breast Implant–Associated Anaplastic Large-Cell Lymphoma in Brazil: What Are We Missing?

Anaplastic large cell lymphoma associated with breast implants. Importance for the surgeon

Linfoma anaplásico de células grandes asociado a implantes mamarios. Importancia para el cirujano

Contact Info

Product

Resources

About